Orris

When does hypervitaminosis of vitamin A occur?

Reading File
Finding Sources
Reading File

Hypervitaminosis A

Vitamin A toxicity occurs in two distinct clinical patterns:

1. Acute hypervitaminosis A

Occurs after ingestion of a single very large dose of vitamin A (classically tens of thousands to hundreds of thousands of IU at once). Historically described after eating polar bear, whale, shark, or tuna liver (extremely rich in vitamin A) - first recorded in 1597 by a ship's carpenter, Gerrit de Veer, stranded in the Arctic after his crew ate polar bear liver.
Presents with headache, dizziness, vomiting, stupor, and blurred vision - a picture that can mimic a brain tumor (pseudotumor cerebri / raised intracranial pressure).

2. Chronic hypervitaminosis A

Occurs with long-term excessive intake, typically:
  • Doses exceeding ~50,000 IU/day for more than 3 months (self-medication, excessive supplementation, or inappropriate high-dose therapy)
  • Use of synthetic retinoids (e.g., isotretinoin) for conditions like acne or ichthyosis, especially without stopping vitamin A supplements concurrently
  • Reported in children most often among chronic cases, and in specific populations such as Alaska Natives who traditionally consume large amounts of vitamin A-rich foods, and in a familial cluster of siblings treated with high-dose vitamin A for congenital ichthyosis (genetic susceptibility factors may play a role)
  • Rarely in burn victims with renal compromise, where impaired clearance contributes
Chronic toxicity develops once vitamin A is stored in the liver beyond a threshold (liver retinol/retinyl ester content exceeding roughly 3000 micrograms/gram of tissue), leading to:
  • Weight loss, anorexia, nausea, vomiting
  • Bone and joint pain (retinoic acid stimulates osteoclast activity, increasing bone resorption and fracture risk)
  • Hepatotoxicity - deposition of excess vitamin A in fat-storing (perisinusoidal/Ito) cells of the liver with perisinusoidal fibrosis, which can progress to cirrhosis (considered the most significant long-term effect)
  • Skin changes, alopecia, and in some cases pseudotumor cerebri
Important exception: synthetic retinoids used for acne treatment are not typically associated with the same toxicity profile, but they carry well-established teratogenic risk and must be avoided in pregnancy.
Sources:
  • Robbins, Cotran & Kumar Pathologic Basis of Disease, Table 9.10 discussion (Vitamin A Toxicity)
  • Yamada's Textbook of Gastroenterology, 7th ed. (Toxicity section)
  • Andrews' Diseases of the Skin (Hypervitaminosis A)
  • Tietz Textbook of Laboratory Medicine, 7th ed. (Toxicity section)
This is a well-established pathology/nutrition fact with no conflicting recent evidence to flag - a targeted current-literature check isn't needed here since the mechanism and dosing thresholds are long-settled physiology rather than an evolving clinical guideline.

What are the parameters to determine hypervitaminosis of vitamin A

Finding Sources
Finding Sources
Reading File
Reading File

Parameters Used to Determine Hypervitaminosis A

Diagnosis relies on a combination of dose/duration history, biochemical (lab) markers, clinical findings, and (occasionally) liver biopsy or imaging. The key parameters are:

1. Dose and duration thresholds (history)

  • Acute toxicity: a single large dose ingested over hours to days (e.g., excessive supplement ingestion, or historically eating polar bear/whale/shark/tuna liver).
  • Chronic toxicity: sustained excessive intake, generally defined as more than 30,000 mcg/day (or >50,000 IU/day) for months to years. In infants, chronic toxicity has been reported with doses of 5,500-6,750 mcg/day over months.
  • The elderly develop toxicity at lower doses, because delayed postprandial clearance of lipoproteins prolongs exposure to retinyl esters.

2. Biochemical/laboratory parameters

  • Plasma/serum vitamin A (retinol) concentration: toxicity is generally associated with levels exceeding 140 mcg/dL (4.9 micromol/L). (Normal range is roughly 20-65 mcg/dL, per parenteral nutrition monitoring data.)
  • Liver retinol/retinyl ester storage: hypervitaminosis A occurs once hepatic storage exceeds 3000 mcg/g of liver tissue (only assessable via biopsy, so used more as a pathophysiologic threshold than a routine test).
  • Serum retinyl ester fraction: normally most circulating vitamin A is bound to retinol-binding protein (RBP)/transthyretin. In toxicity, RBP transport becomes saturated and unbound (free) retinyl esters rise as a proportion of total circulating vitamin A - this "free retinyl ester" elevation is a more specific marker of toxic exposure than total retinol alone.
  • Retinol-binding protein (RBP) and prealbumin (transthyretin) levels - used as supportive nutritional/transport markers, since RBP-retinol-prealbumin complex governs safe transport; low RBP can also reflect liver disease rather than toxicity, so it is interpreted alongside retinol levels.
  • Liver function tests (LFTs): transaminase elevation reflects associated hepatotoxicity.
  • Serum calcium: hypercalcemia can occur as a toxic manifestation.

3. Clinical parameters (symptom-based)

  • Acute: headache, dizziness, nausea/vomiting, abdominal pain, blurred vision, irritability, sluggishness, followed within days by skin desquamation; can mimic a brain tumor (pseudotumor cerebri/raised intracranial pressure).
  • Chronic: bone and joint pain, alopecia, dry/fissured lips, anorexia, weight loss, hepatomegaly, benign intracranial hypertension, and skeletal changes (in infants: bulging fontanelle and skeletal abnormalities).
  • Bone density/fracture risk: intakes only twice the RDA have been associated with osteoporosis and hip fracture risk in epidemiologic studies.

4. Histologic/imaging parameters (when biopsy is done)

  • Liver biopsy: shows hypertrophy of hepatic stellate (Ito) cells engorged with vitamin A, with perisinusoidal fibrosis that can progress to cirrhosis - considered the most significant long-term structural finding.
  • Skeletal imaging: can show cortical hyperostosis or other bone changes in chronic pediatric toxicity.

Practical takeaway

No single lab value is diagnostic in isolation - the combination of (a) a compatible high-dose intake history, (b) elevated serum retinol/free retinyl esters, and (c) compatible clinical features (bone pain, hepatomegaly, raised intracranial pressure, skin changes) is used to confirm hypervitaminosis A. Liver biopsy is reserved for confirming hepatotoxicity when the diagnosis is unclear.
Sources:
  • Tietz Textbook of Laboratory Medicine, 7th ed. - Toxicity section (retinol/retinyl ester thresholds, plasma concentration cutoff)
  • Robbins, Cotran & Kumar Pathologic Basis of Disease - Vitamin A Toxicity
  • Yamada's Textbook of Gastroenterology, 7th ed. - Toxicity section
  • Sleisenger and Fordtran's Gastrointestinal and Liver Disease - Retinol-binding protein transport
  • Fitzpatrick's Dermatology - Vitamin A Toxicity (Chap. 123)
This information reflects well-established, longstanding toxicology thresholds rather than an evolving guideline area, so no conflicting recent evidence check was necessary.
This is a shared conversation. Sign in to Orris to start your own chat.